These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8233629)

  • 1. [Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria].
    Ximenes E; Zuccarelli M; Dusart G; Simeon De Buochberg M
    Pathol Biol (Paris); 1993 Apr; 41(4):317-22. PubMed ID: 8233629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
    Gevaudan MJ; Bollet C; Mallet MN; de Micco P
    Pathol Biol (Paris); 1991 May; 39(5):436-41. PubMed ID: 1652732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of antibiotic penetration in the antimicrobial resistance of biofilm formed by non-pigmented rapidly growing mycobacteria against amikacin, ciprofloxacin and clarithromycin.
    Ortíz-Pérez A; Martín-de-Hijas N; Alonso-Rodríguez N; Molina-Manso D; Fernández-Roblas R; Esteban J
    Enferm Infecc Microbiol Clin; 2011 Feb; 29(2):79-84. PubMed ID: 21333405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
    Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.
    Cremades R; Santos A; Rodríguez JC; García-Pachón E; Ruiz M; Escribano I; Royo G
    Chemotherapy; 2009; 55(2):114-8. PubMed ID: 19155619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the extra- and intracellular activity of clarithromycin against Mycobacterium chelonae].
    Gevaudan MJ; Bollet C; de Micco P
    Pathol Biol (Paris); 1994 May; 42(5):412-8. PubMed ID: 7824305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transamination processes in mycobacteria with different biological properties].
    Fadeeva NI; Golyshevskaia VI; Bibergal' EA; Safonova SG
    Probl Tuberk; 1990; (9):62-4. PubMed ID: 2274513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
    Foroumadi A; Soltani F
    Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime].
    Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans.
    Sáez-López E; Millán-Placer AC; Lucía A; Ramón-García S
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0011867. PubMed ID: 38573915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
    Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
    Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
    Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
    Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
    Mizutani S
    Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic combinations of clarithromycin with doxycycline or minocycline reduce the emergence of antimicrobial resistance in Rhodococcus equi.
    Erol E; Shaffer CL; Lubbers BV
    Equine Vet J; 2021 Sep; ():. PubMed ID: 34480367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.